The warfarin drug market is anticipated to grow at a significant CAGR of 9.7% during the forecast period (2022-2028). Warfarin drug is used as a blood thinner to treat blood clots from forming in the arteries and blood vessels. Blood clots can lead to life-threatening conditions such as heart attack and stroke. Warfarin can reduce the risk of stroke and heart attack in the body. Certain conditions which increase the chance of developing a blood clot in the body include irregular heart rhythm and heart valve replacement. People who experience heart attacks can develop blood clots in the body. Certain surgery such as hip or knee replacement can also lead to a blood clot. Warfarin comes under an umbrella term known as an anticoagulant. This drug reduces the number of clotting proteins in the blood. Warfarin is prescribed for conditions such as pulmonary embolism, venous thrombosis, and arrhythmias. Increasng prevalence of cardiovascular diseases has surged the demand for warfarin drug. In addition, the new drug launch by prominent players in the market are expected to offer numerous growth opportunities.
The global warfarin drug market is segmented by disease and by the end-user. Based on disease, the market is sub-segmented into a pulmonary embolism, venous thrombosis, arrhythmias, and others. Based on end-user, the market is sub-segmented into hospitals, clinics, and others. Pulmonary embolism is a condition in which a blockage takes place in the pulmonary artery. The pulmonary artery is a part of the lungs. This condition takes place due to a blood clot that happens in the lungs and this artery travels from the lungs to the legs thereby causing malfunction. This condition becomes dangerous if not dealt with timely. Common symptoms of this disease are shortness of breath, chest pain, and cough. The prevalence rate of pulmonary embolism is 39 to 115 per 100,000 population annually. Pulmonary embolism is the third most common cardiovascular disease after coronary artery and stroke. The prevalence of pulmonary embolism is more in males than in females. The mortality rate of this disease is high and it causes 100,000 deaths in the United States in a year.
The global diquafosol market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). Among them, North America is expected to drive the market during the forecast period. A major reason for this is the high prevalence of venous thrombosis in this region.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Global Warfarin Drug Market at https://orionmarketreports.com/request-sample/?id=109760&submit=Request+Sample%0D%0A
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Disease
- By End-User
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape- Teva Pharmaceutical Industries Ltd., Cipla Inc., BRISTOL MYERS SQUIBB, Zydus Pharmaceuticals, Inc.
A full report is available at: https://orionmarketreports.com/global-warfarin-drug-market/109760/
Warfarin Drug Market Report by Segment
By Disease
- Pulmonary Embolism
- Venous Thrombosis
- Arrhythmias
- Others
By End-User
- Hospital
- Clinic
- Others
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
